Medscape

FDA Safety Changes: Keppra, Naropin, Rebetol

December 22, 2006 - The US Food and Drug Administration (FDA) has approved safety label revisions to advise of the expected similarity of levetiracetam's safety profile in patients with juvenile ...
Medscape

FDA Safety Labeling Changes: Vivelle, Junior Advil, Lotrel, Naropin

Nov. 10, 2004 — The U.S. Food and Drug Administration (FDA) approved in August revisions to drug safety labeling to advise healthcare professionals of the following changes: estradiol transdermal ...
Monthly Prescribing Reference

Naropin 2% Launched in New Freeflex Containers

Naropin 2% Launched in New Freeflex Containers Fresenius Kabi announced that the Food and Drug Administration (FDA) has approved the launch of Naropin (ropivacaine HCl) injection in the company's ...
EurekAlert!

Naropin® now approved for intrathecal (spinal) administration in the European Union (EU)

Södertälje, Sweden, 3 March 2004 - AstraZeneca announced today that its long-acting local anaesthetic Naropin® (ropivacaine) 5.0 mg/ml was recommended for approval in all EU member states for a new ...